Product Name   :    Irbesartan 50% + Hydrochlorthiazide 4.16% DC Granules
Dosage Form   :    Tablets
Dose   :    150/12.5mg
Reference Product   :    Avalide
API : DMF; Dossier — CTD   :    Available
Originator   :    Sanofi-aventis
Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It was developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.
Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It was developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.